217 related articles for article (PubMed ID: 33683595)
21. [Next generation sequencing technology for susceptible gene screening in familial non-medullary thyroid carcinoma].
Dong L; Yu Y; Yu JP; Hao WJ; Zheng XQ; Cheng YN; Han L; Zhao JZ; Gao M
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):24-28. PubMed ID: 28104029
[No Abstract] [Full Text] [Related]
22.
Orois A; Gara SK; Mora M; Halperin I; Martínez S; Alfayate R; Kebebew E; Oriola J
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31703244
[TBL] [Abstract][Full Text] [Related]
23. HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer.
Weeks AL; Wilson SG; Ward L; Goldblatt J; Hui J; Walsh JP
BMC Med Genet; 2016 Aug; 17(1):60. PubMed ID: 27530615
[TBL] [Abstract][Full Text] [Related]
24.
Stolarova L; Kleiblova P; Janatova M; Soukupova J; Zemankova P; Macurek L; Kleibl Z
Cells; 2020 Dec; 9(12):. PubMed ID: 33322746
[TBL] [Abstract][Full Text] [Related]
25. HABP2 G534E Variant in Papillary Thyroid Carcinoma.
Tomsic J; Fultz R; Liyanarachchi S; He H; Senter L; de la Chapelle A
PLoS One; 2016; 11(1):e0146315. PubMed ID: 26745718
[TBL] [Abstract][Full Text] [Related]
26. Identification of
Marques IJ; Gomes I; Pojo M; Pires C; Moura MM; Cabrera R; Santos C; van IJcken WFJ; Teixeira MR; Ramalho JS; Leite V; Cavaco BM
Thyroid; 2021 Sep; 31(9):1366-1375. PubMed ID: 33906393
[No Abstract] [Full Text] [Related]
27. The
Brandão A; Paulo P; Maia S; Pinheiro M; Peixoto A; Cardoso M; Silva MP; Santos C; Eeles RA; Kote-Jarai Z; Muir K; Ukgpcs Collaborators ; Schleutker J; Wang Y; Pashayan N; Batra J; Apcb BioResource ; Grönberg H; Neal DE; Nordestgaard BG; Tangen CM; Southey MC; Wolk A; Albanes D; Haiman CA; Travis RC; Stanford JL; Mucci LA; West CML; Nielsen SF; Kibel AS; Cussenot O; Berndt SI; Koutros S; Sørensen KD; Cybulski C; Grindedal EM; Park JY; Ingles SA; Maier C; Hamilton RJ; Rosenstein BS; Vega A; The Impact Study Steering Committee And Collaborators ; Kogevinas M; Wiklund F; Penney KL; Brenner H; John EM; Kaneva R; Logothetis CJ; Neuhausen SL; Ruyck K; Razack A; Newcomb LF; Canary Pass Investigators ; Lessel D; Usmani N; Claessens F; Gago-Dominguez M; Townsend PA; Roobol MJ; The Profile Study Steering Committee ; The Practical Consortium ; Teixeira MR
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33158149
[TBL] [Abstract][Full Text] [Related]
28. CHEK2 1100delC and Del5395bp mutations in BRCA-negative individuals from Serbian hereditary breast and ovarian cancer families.
Krivokuca A; Dobricic J; Brankovic-Magic M
J BUON; 2013; 18(3):594-600. PubMed ID: 24065469
[TBL] [Abstract][Full Text] [Related]
29. Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis.
Cavaco BM; Batista PF; Sobrinho LG; Leite V
J Clin Endocrinol Metab; 2008 Nov; 93(11):4426-30. PubMed ID: 18765515
[TBL] [Abstract][Full Text] [Related]
30. Familial non-medullary thyroid cancer: unraveling the genetic maze.
Peiling Yang S; Ngeow J
Endocr Relat Cancer; 2016 Dec; 23(12):R577-R595. PubMed ID: 27807061
[TBL] [Abstract][Full Text] [Related]
31. [Clinical features of 17 patients with familial non medullary thyroid carcinoma].
Mosso L; Velasco S; Salazar I; Solar A; González H; Cardona B; Fardella C; González G; López JM; Rodríguez JA; Cruz F; Arteaga E
Rev Med Chil; 2007 Jun; 135(6):718-24. PubMed ID: 17728897
[TBL] [Abstract][Full Text] [Related]
32. Two types of recessive hereditary spastic paraplegia in Roma patients in compound heterozygous state; no ethnically prevalent variant found.
Meszarosova AU; Seeman P; Jencik J; Drabova J; Cibochova R; Stellmachova J; Safka Brozkova D
Neurosci Lett; 2020 Mar; 721():134800. PubMed ID: 32007496
[TBL] [Abstract][Full Text] [Related]
33. Novel Susceptibility Genes Drive Familial Non-Medullary Thyroid Cancer in a Large Consanguineous Kindred.
Majdalani P; Yoel U; Nasasra T; Fraenkel M; Haim A; Loewenthal N; Zarivach R; Hershkovitz E; Parvari R
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175943
[TBL] [Abstract][Full Text] [Related]
34. Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid.
Burgess JR; Duffield A; Wilkinson SJ; Ware R; Greenaway TM; Percival J; Hoffman L
J Clin Endocrinol Metab; 1997 Feb; 82(2):345-8. PubMed ID: 9024215
[TBL] [Abstract][Full Text] [Related]
35. Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance.
Kleiblová P; Stolařová L; Křížová K; Lhota F; Hojný J; Zemánková P; Havránek O; Vočka M; Černá M; Lhotová K; Borecká M; Janatová M; Soukupová J; Ševčík J; Zimovjanová M; Kotlas J; Panczak A; Veselá K; Červenková J; Schneiderová M; Burócziová M; Burdová K; Stránecký V; Foretová L; Macháčková E; Tavandzis S; Kmoch S; Macůrek L; Kleibl Z
Klin Onkol; 2019; 32(Supplementum2):36-50. PubMed ID: 31409080
[TBL] [Abstract][Full Text] [Related]
36. Frequent and Rare HABP2 Variants Are Not Associated with Increased Susceptibility to Familial Nonmedullary Thyroid Carcinoma in the Spanish Population.
de Randamie R; Martos-Moreno GÁ; Lumbreras C; Chueca M; Donnay S; Luque M; Regojo RM; Mendiola M; Hardisson D; Argente J; Moreno JC
Horm Res Paediatr; 2018; 89(6):397-407. PubMed ID: 29895015
[TBL] [Abstract][Full Text] [Related]
37. Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment.
Musholt TJ; Musholt PB; Petrich T; Oetting G; Knapp WH; Klempnauer J
World J Surg; 2000 Nov; 24(11):1409-17. PubMed ID: 11038215
[TBL] [Abstract][Full Text] [Related]
38. [Impact of germline BRCA2 and CHEK2 mutations on time to castration resistance in patients with metastatic hormone-nave prostate cancer].
Matveev VB; Kirichek AA; Filippova MG; Savinkova AV; Khalmurzaev OA; Lyubchenko LN
Urologiia; 2019 Dec; (5):79-85. PubMed ID: 31808637
[TBL] [Abstract][Full Text] [Related]
39. Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations.
Cavaco BM; Batista PF; Martins C; Banito A; do Rosário F; Limbert E; Sobrinho LG; Leite V
Endocr Relat Cancer; 2008 Mar; 15(1):207-15. PubMed ID: 18310288
[TBL] [Abstract][Full Text] [Related]
40. Identification of susceptibility gene mutations associated with the pathogenesis of familial nonmedullary thyroid cancer.
Zhu J; Wu K; Lin Z; Bai S; Wu J; Li P; Xue H; Du J; Shen B; Wang H; Liu Y
Mol Genet Genomic Med; 2019 Dec; 7(12):e1015. PubMed ID: 31642198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
